Advance your academic career, collaborate globally, and expand your network— join now !

Due to scheduled maintenance work on our database systems, there may be short service disruptions on this website between 10:00 and 11:00 CEST on June 14th.

Prof. Elrashdy M. Redwan

Biological Science,  King Abdulaziz University

Share Link

Share

Information

Prof. Dr. Elrashy M. Redwan is currently a Sabbatical Professor at the Biological Science Department, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia. He obtained his Ph.D. in biomedicine and immunology from Cairo University of Egypt (1995) and was promoted to a permanent senior researcher position at the Department of Biomedical Research, VACSERA. In 1998, he was nominated for a permanent professorship at the City for Scientific Research and Technology Applications (New Borg Alrab, Alexandria 21934, Egypt). For two years, he worked as a visiting scientist at the Scripps Research Institute (TSRI, San Diego) on monoclonal antibody humanization and crystallization. Over the past 20 years, he has focused his scientific research on topics related to life-treating infectious diseases, such as enteric pathogens, Haemophilus influenzae type B virus (HIb), hepatitis C virus (HCV), and hepatitis B virus (HBV). He also looks for roles of natural products as potential anti-viral and anti-bacterial alternative medicine. He has established a cluster of platforms for the production of new biopharmaceuticals and/or biosimilars. He served as an expert in national organizations, such as the Egyptian Academy of Scientific Research and Technologies. He has received many national academic honors (2008, 2009, and 2010).

Research Keywords & Expertise

Immunochemistry
viral host interaction...
biopharmaceutical prod...
Antimicrobial drug dev...
Microbiology Immunolog...

Fingerprints

5%
biopharmaceutical products

Short Biography

Prof. Dr. Elrashy M. Redwan is currently a Sabbatical Professor at the Biological Science Department, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia. He obtained his Ph.D. in biomedicine and immunology from Cairo University of Egypt (1995) and was promoted to a permanent senior researcher position at the Department of Biomedical Research, VACSERA. In 1998, he was nominated for a permanent professorship at the City for Scientific Research and Technology Applications (New Borg Alrab, Alexandria 21934, Egypt). For two years, he worked as a visiting scientist at the Scripps Research Institute (TSRI, San Diego) on monoclonal antibody humanization and crystallization. Over the past 20 years, he has focused his scientific research on topics related to life-treating infectious diseases, such as enteric pathogens, Haemophilus influenzae type B virus (HIb), hepatitis C virus (HCV), and hepatitis B virus (HBV). He also looks for roles of natural products as potential anti-viral and anti-bacterial alternative medicine. He has established a cluster of platforms for the production of new biopharmaceuticals and/or biosimilars. He served as an expert in national organizations, such as the Egyptian Academy of Scientific Research and Technologies. He has received many national academic honors (2008, 2009, and 2010).